279 related articles for article (PubMed ID: 30718450)
21. Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study.
Le Jeune F; Vérin M; N'Diaye K; Drapier D; Leray E; Du Montcel ST; Baup N; Pelissolo A; Polosan M; Mallet L; Yelnik J; Devaux B; Fontaine D; Chereau I; Bourguignon A; Peron J; Sauleau P; Raoul S; Garin E; Krebs MO; Jaafari N; Millet B;
Biol Psychiatry; 2010 Dec; 68(11):1016-22. PubMed ID: 20951978
[TBL] [Abstract][Full Text] [Related]
22. Deep brain stimulation for obsessive-compulsive disorder: is the side relevant?
Barcia JA; Reyes L; Arza R; Saceda J; Avecillas J; Yáñez R; García-Albea J; Ortiz T; López-Ibor MI; López-Ibor JJ
Stereotact Funct Neurosurg; 2014; 92(1):31-6. PubMed ID: 24216976
[TBL] [Abstract][Full Text] [Related]
23. Topography of emotional valence and arousal within the motor part of the subthalamic nucleus in Parkinson's disease.
Serranová T; Sieger T; Růžička F; Bakštein E; Dušek P; Vostatek P; Novák D; Růžička E; Urgošík D; Jech R
Sci Rep; 2019 Dec; 9(1):19924. PubMed ID: 31882633
[TBL] [Abstract][Full Text] [Related]
24. Reward circuit DBS improves Parkinson's gait along with severe depression and OCD.
Williams NR; Hopkins TR; Short EB; Sahlem GL; Snipes J; Revuelta GJ; George MS; Takacs I
Neurocase; 2016; 22(2):201-4. PubMed ID: 26644268
[TBL] [Abstract][Full Text] [Related]
25. Neuropsychiatric effects of subthalamic deep brain stimulation.
Mosley PE; Akram H
Handb Clin Neurol; 2021; 180():417-431. PubMed ID: 34225945
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of distinct populations of subthalamic nucleus neurons on Parkinson's disease and OCD-like behaviors in mice.
Parolari L; Schneeberger M; Heintz N; Friedman JM
Mol Psychiatry; 2021 Nov; 26(11):7029-7046. PubMed ID: 34099874
[TBL] [Abstract][Full Text] [Related]
28. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
29. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
[TBL] [Abstract][Full Text] [Related]
30. Concerning neuromodulation as treatment of neurological and neuropsychiatric disorder: Insights gained from selective targeting of the subthalamic nucleus, para-subthalamic nucleus and zona incerta in rodents.
Ricci A; Rubino E; Serra GP; Wallén-Mackenzie Å
Neuropharmacology; 2024 Sep; 256():110003. PubMed ID: 38789078
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
32. Processing of emotional information in the human subthalamic nucleus.
Buot A; Welter ML; Karachi C; Pochon JB; Bardinet E; Yelnik J; Mallet L
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1331-8. PubMed ID: 23100448
[TBL] [Abstract][Full Text] [Related]
33. Subthalamic deep brain stimulation aggravates speech problems in Parkinson's disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location.
Phokaewvarangkul O; Boonpang K; Bhidayasiri R
Parkinsonism Relat Disord; 2019 Sep; 66():110-116. PubMed ID: 31327627
[TBL] [Abstract][Full Text] [Related]
34. Modulation of motor inhibition by subthalamic stimulation in obsessive-compulsive disorder.
Kibleur A; Gras-Combe G; Benis D; Bastin J; Bougerol T; Chabardès S; Polosan M; David O
Transl Psychiatry; 2016 Oct; 6(10):e922. PubMed ID: 27754484
[TBL] [Abstract][Full Text] [Related]
35. Emotion recognition in Parkinson's disease after subthalamic deep brain stimulation: differential effects of microlesion and STN stimulation.
Aiello M; Eleopra R; Lettieri C; Mondani M; D'Auria S; Belgrado E; Piani A; De Simone L; Rinaldo S; Rumiati RI
Cortex; 2014 Feb; 51():35-45. PubMed ID: 24342106
[TBL] [Abstract][Full Text] [Related]
36. Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease.
Serranová T; Jech R; Dušek P; Sieger T; Růžička F; Urgošík D; Růžička E
Mov Disord; 2011 Oct; 26(12):2260-6. PubMed ID: 21780183
[TBL] [Abstract][Full Text] [Related]
37. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report.
Fontaine D; Mattei V; Borg M; von Langsdorff D; Magnie MN; Chanalet S; Robert P; Paquis P
J Neurosurg; 2004 Jun; 100(6):1084-6. PubMed ID: 15200126
[TBL] [Abstract][Full Text] [Related]
38. [A proposed new target for deep brain stimulation in obsessive-compulsive disorder].
Seijo-Zazo E; Seijo-Fernández F; Fernández-González F; Alvarez-Vega MA; Lozano-Aragoneses B
Rev Neurol; 2007 Oct 1-15; 45(7):424-8. PubMed ID: 17918109
[TBL] [Abstract][Full Text] [Related]
39. Dopamine replacement therapy and deep brain stimulation of the subthalamic nuclei induce modulation of emotional processes at different spatial frequencies in Parkinson's disease.
Mermillod M; Mondillon L; Rieu I; Devaux D; Chambres P; Auxiette C; Dalens H; Coulangeon LM; Jalenques I; Durif F
J Parkinsons Dis; 2014; 4(1):97-110. PubMed ID: 24496100
[TBL] [Abstract][Full Text] [Related]
40. Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.
Hidding U; Gulberti A; Pflug C; Choe C; Horn A; Prilop L; Braaß H; Fründt O; Buhmann C; Weiss D; Westphal M; Engel AK; Gerloff C; Köppen JA; Hamel W; Moll CKE; Pötter-Nerger M
Parkinsonism Relat Disord; 2019 May; 62():141-147. PubMed ID: 30616868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
